MultiCell Technologies, Inc. (MCET)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Aug 1, 2025, 3:37 PM EDT
MultiCell Technologies Revenue
MultiCell Technologies had revenue of $194.77K in the quarter ending August 31, 2015, with 1,479.79% growth. This brings the company's revenue in the last twelve months to $805.24K, up 1,532.74% year-over-year. In the fiscal year ending November 30, 2014, MultiCell Technologies had annual revenue of $49.32K.
Revenue (ttm)
805.24K
Revenue Growth
+1,532.74%
P/S Ratio
0.01
Revenue / Employee
402.62K
Employees
2
Market Cap
5.00K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2014 | 49.32K | - | - |
Nov 30, 2013 | 49.32K | - | - |
Nov 30, 2012 | 49.32K | - | - |
Nov 30, 2011 | 49.32K | -49.54K | -50.11% |
Nov 30, 2010 | 98.86K | -75.38K | -43.26% |
Nov 30, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
American Oncology Network | 1.76B |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |